881. Safety, Efficacy and Biodistribution of Recombinant AAV2-RPE65 Vector Delivered by Ocular Subretinal InjectionSamuel G. Jacobson, William W. Hauswirth, Geoffrey K. Aguirre et al.|Molecular Therapy|2006Cited by 0